Drug intelligence / Profile preview

Dengue Fever Vaccine (Multi-epitope Peptide)

Development stage
Preclinical
Lead developer
Asia Biotech
Modality
Peptides, Vaccines & Immunotherapeutics
01

Overview

Dengue Fever Vaccine (Multi-epitope Peptide) is an epitope-based vaccine candidate developed by Asia Biotech for the prevention of Dengue fever. The vaccine is designed to target all four serotypes of the dengue virus (DENV-1, DENV-2, DENV-3, and DENV-4) by presenting conserved peptide epitopes to the host immune system. This multi-epitope approach, developed using Asia Biotech's Epitope Platform, aims to induce broad and cross-reactive protective immunity against the virus. As of the latest pipeline reports, the candidate is in the preclinical stage of development.

Other names
Dengue multi-epitope peptide vaccineepitope-based vaccinemulti-epitope peptide vaccine
02

Targets

TLR4 (Toll-like receptor 4)TLR3 (Toll-like receptor 3)TLR5NS1 (Zika virus nonstructural protein 1)E (Tick-borne encephalitis virus envelope protein)

Beyond the preview

Go deeper on Dengue Fever Vaccine (Multi-epitope Peptide).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dengue Fever Vaccine (Multi-epitope Peptide).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call